These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15758585)

  • 61. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preventing hospitalization for COPD exacerbations.
    Bourbeau J
    Semin Respir Crit Care Med; 2010 Jun; 31(3):313-20. PubMed ID: 20496300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD.
    Leivo-Korpela S; Lehtimäki L; Vuolteenaho K; Nieminen R; Kööbi L; Järvenpää R; Kankaanranta H; Saarelainen S; Moilanen E
    Respir Med; 2014 Jan; 108(1):122-8. PubMed ID: 24135487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Contemporary strategy and guideline of COPD therapy].
    Płusa T
    Pol Merkur Lekarski; 2009 Dec; 27(162):447-52. PubMed ID: 20120704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Diagnosis and treatment of COPD].
    Nagai A
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():137-40. PubMed ID: 11989253
    [No Abstract]   [Full Text] [Related]  

  • 71. Chronic Obstructive Pulmonary Disease : Tunisian Society of Respiratory Diseases and Allergology Guidelines.
    Kammoun S; Hayouni A; Ghrairi H; Racil H; Rouetbi N; Garrouche A; Gargouri I; Ben Younes R; Maatallah A; Slama S; Smaoui M; Bali F; Tritar F; Charfi MR
    Tunis Med; 2017; 95(8-9):722-733. PubMed ID: 29873044
    [No Abstract]   [Full Text] [Related]  

  • 72. Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2005; 2(1):83-93. PubMed ID: 16113474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exacerbation of chronic obstructive pulmonary disease.
    Ismail TS
    Med J Malaysia; 2009 Sep; 64(3):250-5; quiz 256. PubMed ID: 20527283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minimizing the impact of chronic obstructive pulmonary disease.
    Winn G
    Case Manager; 2000; 11(6):45-8; quiz 49. PubMed ID: 11935838
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
    Cazzola M
    Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term nonpharmacologic management of patients with chronic obstructive pulmonary disease.
    Doherty DE; Briggs DD
    Clin Cornerstone; 2004; Suppl 2():S29-34. PubMed ID: 15500181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.
    Fritsch K; Jacot ML; Klarer A; Wick F; Bruggmann P; Krause M; Thurnheer R
    Swiss Med Wkly; 2005 Feb; 135(7-8):116-21. PubMed ID: 15832228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pharmacological approach to the elderly COPD patient.
    Albertson TE; Schivo M; Zeki AA; Louie S; Sutter ME; Avdalovic M; Chan AL
    Drugs Aging; 2013 Jul; 30(7):479-502. PubMed ID: 23580319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [COPD - non - pharmacological management and pulmonary rehabilitation].
    Schultz K
    MMW Fortschr Med; 2014 Nov; 156 Spec no 2():44-9; quiz 50. PubMed ID: 25552019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.